vs

Side-by-side financial comparison of Marygold Companies, Inc. (MGLD) and Semler Scientific, Inc. (SMLR). Click either name above to swap in a different company.

Marygold Companies, Inc. is the larger business by last-quarter revenue ($7.6M vs $7.5M, roughly 1.0× Semler Scientific, Inc.). Semler Scientific, Inc. runs the higher net margin — 225.6% vs -7.5%, a 233.2% gap on every dollar of revenue. On growth, Marygold Companies, Inc. posted the faster year-over-year revenue change (-4.5% vs -44.6%). Over the past eight quarters, Marygold Companies, Inc.'s revenue compounded faster (-1.5% CAGR vs -29.5%).

Marygold Companies, Inc. is a U.S.-headquartered diversified holding company that operates across three core segments: financial services, specialty manufacturing, and consumer goods. It primarily caters to North American markets, driving long-term value growth via strategic investment in, and operational optimization of, its portfolio of subsidiary entities.

Semler Scientific, Inc. develops, manufactures and distributes non-invasive medical diagnostic devices for chronic disease screening. Its flagship QuantaFlo system delivers fast, accurate peripheral arterial disease testing, serving hospitals, clinics, primary care practices and other healthcare providers primarily in the United States.

MGLD vs SMLR — Head-to-Head

Bigger by revenue
MGLD
MGLD
1.0× larger
MGLD
$7.6M
$7.5M
SMLR
Growing faster (revenue YoY)
MGLD
MGLD
+40.1% gap
MGLD
-4.5%
-44.6%
SMLR
Higher net margin
SMLR
SMLR
233.2% more per $
SMLR
225.6%
-7.5%
MGLD
Faster 2-yr revenue CAGR
MGLD
MGLD
Annualised
MGLD
-1.5%
-29.5%
SMLR

Income Statement — Q2 FY2026 vs Q3 FY2025

Metric
MGLD
MGLD
SMLR
SMLR
Revenue
$7.6M
$7.5M
Net Profit
$-576.0K
$16.9M
Gross Margin
74.0%
91.5%
Operating Margin
-8.3%
-72.0%
Net Margin
-7.5%
225.6%
Revenue YoY
-4.5%
-44.6%
Net Profit YoY
67.0%
201.3%
EPS (diluted)
$-0.01
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MGLD
MGLD
SMLR
SMLR
Q4 25
$7.6M
Q3 25
$7.0M
$7.5M
Q2 25
$7.2M
$8.2M
Q1 25
$7.0M
$8.8M
Q4 24
$8.0M
$12.4M
Q3 24
$7.9M
$13.5M
Q2 24
$8.3M
$14.5M
Q1 24
$7.9M
$15.9M
Net Profit
MGLD
MGLD
SMLR
SMLR
Q4 25
$-576.0K
Q3 25
$-356.0K
$16.9M
Q2 25
$-1.5M
$66.9M
Q1 25
$-1.0M
$-64.7M
Q4 24
$-1.7M
$29.2M
Q3 24
$-1.6M
$5.6M
Q2 24
$-1.9M
$11.0K
Q1 24
$-529.0K
$6.1M
Gross Margin
MGLD
MGLD
SMLR
SMLR
Q4 25
74.0%
Q3 25
77.0%
91.5%
Q2 25
67.8%
91.0%
Q1 25
75.0%
89.4%
Q4 24
74.1%
91.1%
Q3 24
73.1%
91.4%
Q2 24
72.5%
91.3%
Q1 24
70.5%
92.2%
Operating Margin
MGLD
MGLD
SMLR
SMLR
Q4 25
-8.3%
Q3 25
-18.2%
-72.0%
Q2 25
-16.5%
-25.0%
Q1 25
-21.4%
-352.0%
Q4 24
-22.8%
28.5%
Q3 24
-27.4%
37.5%
Q2 24
-33.3%
37.0%
Q1 24
-18.7%
43.9%
Net Margin
MGLD
MGLD
SMLR
SMLR
Q4 25
-7.5%
Q3 25
-5.1%
225.6%
Q2 25
-20.4%
814.6%
Q1 25
-14.4%
-732.3%
Q4 24
-21.8%
235.3%
Q3 24
-20.1%
41.5%
Q2 24
-22.5%
0.1%
Q1 24
-6.7%
38.2%
EPS (diluted)
MGLD
MGLD
SMLR
SMLR
Q4 25
$-0.01
Q3 25
$-0.01
$1.07
Q2 25
$-0.04
$5.04
Q1 25
$-0.02
$-6.74
Q4 24
$-0.04
$3.63
Q3 24
$-0.04
$0.72
Q2 24
$-0.05
$0.00
Q1 24
$-0.01
$0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MGLD
MGLD
SMLR
SMLR
Cash + ST InvestmentsLiquidity on hand
$11.6M
$10.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$22.7M
$459.7M
Total Assets
$27.8M
$596.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MGLD
MGLD
SMLR
SMLR
Q4 25
$11.6M
Q3 25
$12.5M
$10.2M
Q2 25
$12.8M
$13.5M
Q1 25
$15.6M
$9.7M
Q4 24
$14.9M
$8.8M
Q3 24
$17.5M
$6.6M
Q2 24
$15.0M
$7.3M
Q1 24
$16.1M
$62.8M
Stockholders' Equity
MGLD
MGLD
SMLR
SMLR
Q4 25
$22.7M
Q3 25
$22.9M
$459.7M
Q2 25
$23.0M
$383.4M
Q1 25
$24.3M
$161.7M
Q4 24
$23.4M
$230.8M
Q3 24
$25.5M
$85.4M
Q2 24
$26.6M
$78.4M
Q1 24
$28.4M
$77.9M
Total Assets
MGLD
MGLD
SMLR
SMLR
Q4 25
$27.8M
Q3 25
$28.4M
$596.7M
Q2 25
$30.4M
$522.6M
Q1 25
$33.5M
$293.4M
Q4 24
$33.0M
$239.8M
Q3 24
$35.9M
$92.2M
Q2 24
$32.9M
$84.8M
Q1 24
$33.7M
$83.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MGLD
MGLD
SMLR
SMLR
Operating Cash FlowLast quarter
$-908.0K
$-33.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-1.95×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MGLD
MGLD
SMLR
SMLR
Q4 25
$-908.0K
Q3 25
$-533.0K
$-33.0M
Q2 25
$-3.3M
$514.0K
Q1 25
$-1.2M
$-1.9M
Q4 24
$-770.0K
$7.4M
Q3 24
$-893.0K
$6.4M
Q2 24
$-1.9M
$4.9M
Q1 24
$-658.0K
$5.6M
Free Cash Flow
MGLD
MGLD
SMLR
SMLR
Q4 25
Q3 25
$-562.0K
Q2 25
$-3.4M
Q1 25
Q4 24
$-776.0K
$7.4M
Q3 24
$-940.0K
Q2 24
$-2.0M
$4.9M
Q1 24
$5.6M
FCF Margin
MGLD
MGLD
SMLR
SMLR
Q4 25
Q3 25
-8.1%
Q2 25
-46.8%
Q1 25
Q4 24
-9.7%
59.8%
Q3 24
-11.9%
Q2 24
-23.8%
33.8%
Q1 24
35.3%
Capex Intensity
MGLD
MGLD
SMLR
SMLR
Q4 25
0.0%
Q3 25
0.4%
Q2 25
0.7%
Q1 25
0.0%
Q4 24
0.1%
0.0%
Q3 24
0.6%
0.0%
Q2 24
0.7%
0.3%
Q1 24
0.0%
0.0%
Cash Conversion
MGLD
MGLD
SMLR
SMLR
Q4 25
Q3 25
-1.95×
Q2 25
0.01×
Q1 25
Q4 24
0.25×
Q3 24
1.15×
Q2 24
448.55×
Q1 24
0.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MGLD
MGLD

Fund Management Related Party$4.6M60%
Food Products$1.7M22%
Beauty Products$1.2M15%
Other$268.0K4%

SMLR
SMLR

Segment breakdown not available.

Related Comparisons